In an earlier investigation, low-frequency
Raman (LFR) spectroscopy
was shown to detect the transition temperature of the β-relaxation
(T
β) in both amorphous celecoxib
and various celecoxib amorphous solid dispersions [Be̅rziņšK.
Be̅rziņš, K.
Mol. Pharmaceutics20211838823893]. In this study, we further investigated the application
of this technique to determine T
β, an important parameter for estimating crystallization potency of
amorphous drugs. Alongside commercially available amorphous drugs
(zafirlukast and valsartan disodium salt), differently melt-quenched
samples of cimetidine were also analyzed. Overall, the variable-temperature
LFR measurements allowed for an easy access to the desired information,
including the even lesser transition of the tertiary relaxation motions
(T
γ). Thus, the obtained results
not only highlighted the sensitivity, but also the practical usefulness
of this technique to elucidate (subtle) changes in molecular dynamics
within amorphous pharmaceutical systems.